13F

FOLD Amicus Therapeutics Inc

2026Q1 · CUSIP 03152W109 · Sector: Other

🟡 Fading · Price holds, watch
Holders
297
Δ holders QoQ
-34
Breadth percentile
Top 96%
Whale holders
144
Δ whales
-13
Inst. holding value
$5.5B
New positions
54
Closed positions
88
Price momentum (1Q)
Put / Call
4/6

Breadth history (34 quarters)

2018Q1: Δ+21 · h=203 2018Q2: Δ-2 · h=201 2018Q3: Δ+3 · h=204 2018Q4: Δ-10 · h=194 2019Q1: Δ+11 · h=205 2019Q2: Δ+0 · h=205 2019Q3: Δ+3 · h=208 2019Q4: Δ+16 · h=224 2020Q1: Δ-20 · h=204 2020Q2: Δ+23 · h=227 2020Q3: Δ+23 · h=250 2020Q4: Δ+23 · h=273 2021Q1: Δ-17 · h=256 2021Q2: Δ-22 · h=234 2021Q3: Δ+1 · h=235 2021Q4: Δ-10 · h=225 2022Q1: Δ-9 · h=216 2022Q2: Δ-4 · h=212 2022Q3: Δ+8 · h=220 2022Q4: Δ+12 · h=232 2023Q1: Δ-5 · h=227 2023Q2: Δ-10 · h=217 2023Q3: Δ+10 · h=227 2023Q4: Δ-1 · h=226 2024Q1: Δ+24 · h=250 2024Q2: Δ+7 · h=257 2024Q3: Δ+34 · h=291 2024Q4: Δ-1 · h=290 2025Q1: Δ-4 · h=286 2025Q2: Δ-16 · h=270 2025Q3: Δ+17 · h=287 2025Q4: Δ+44 · h=331 2026Q1: Δ-34 · h=297 2018Q1: holders=203 2018Q2: holders=201 2018Q3: holders=204 2018Q4: holders=194 2019Q1: holders=205 2019Q2: holders=205 2019Q3: holders=208 2019Q4: holders=224 2020Q1: holders=204 2020Q2: holders=227 2020Q3: holders=250 2020Q4: holders=273 2021Q1: holders=256 2021Q2: holders=234 2021Q3: holders=235 2021Q4: holders=225 2022Q1: holders=216 2022Q2: holders=212 2022Q3: holders=220 2022Q4: holders=232 2023Q1: holders=227 2023Q2: holders=217 2023Q3: holders=227 2023Q4: holders=226 2024Q1: holders=250 2024Q2: holders=257 2024Q3: holders=291 2024Q4: holders=290 2025Q1: holders=286 2025Q2: holders=270 2025Q3: holders=287 2025Q4: holders=331 2026Q1: holders=297 -44 -22 +0 +22 +44 174261348 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 9 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 12%
2025Q3 Top 20%
2024Q3 Top 8%
2024Q1 Top 12%
2023Q3 Top 18%
2022Q3 Top 16%
2020Q3 Top 10%
2020Q2 Top 15%
2018Q1 Top 9%

Options Sentiment

Put holders
4
QoQ: -5
Call holders
6
QoQ: -5

See methodology →